Authors
Latest:
Unmasking Botulinum Toxin MythsMisleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.
Latest:
Determining Follow-Up Approach in Melanoma Based on GEP Risk LevelAn expert discusses whether the 31-gene expression profile (GEP) risk classification would change treatment guidelines and how the patient’s GEP risk level would influence the approach to surveillance and follow-up.
Latest:
Getting JAK’d With Amy Spizuoco, DO, FAOCDThe JAK inhibitors have demonstrated efficacy, yet some clinicians are still wary of prescribing them. Amy Spizuoco, DO, FAOCD, shares tips to help clinicians improve their comfort in using them.
Latest:
Drug Price Hikes Already Found in 2023List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.
Latest:
Marcella R. Aquino, MD, FACAAI: Don’t Make a Rash DxMarcella R. Aquino details issues in differential diagnosis for rashes that mimic allergic skin conditions at the ACAAI Annual Meeting.
Latest:
Administrative Burden of Prescribing BiologicsPrescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.
Latest:
It's Not Genital Warts: A Clinician's Guide to Reassuring Men's Genital ConcernsIn celebration of Men's Health Month, Hershel Dobkin, MD, FAAD, shed some light on a "taboo" topic.
Latest:
Melanocyte Preservation and Future Directions for Laser TechnologyCheri Frey, MD, discusses how emerging laser technologies are advancing melanocyte-sparing treatments while developing more precise targeting capabilities and enhanced safety features for diverse skin types.
Latest:
A Clinician’s Perspective of RAD 2025: Part 1Maureen Offiah, MD, reflected on the key takeaways as an attendee at the 2025 Revolutionizing Atopic Dermatitis (RAD) Conference in Nashville, Tennessee.
Latest:
Ensure Patient Adherence in Pediatric Atopic Dermatitis CasesSteve Feldman, MD, PhD, is part of an atopic dermatitis panel and focuses on strategies to hold pediatric patients and their parents accountable to treatment methods.
Latest:
Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With PatientsScurto presented integrative medicine pearls at the 2024 Diversity in Dermatology meeting.
Latest:
Pediatric Melanoma in Review: Providing Considerations for DermatologistsPediatric melanoma, though rare, is the deadliest skin cancer in children, with 300-500 US cases annually.
Latest:
Award Recipient to Focus on Atopic Dermatitis in Native AmericansKamran H. Imam, MD, hopes to unlock insights into the atopic disease burden among Native American populations.
Latest:
Johnson & Johnson Submits 2 sBLAs for Guselkumab for Pediatric Psoriasis and Juvenile PsAIf granted, guselkumab will be approved to treat children ages 6 and younger with severe plaque psoriasis and children ages 5 and younger with juvenile psoriatic arthritis.
Latest:
Study: Lifestyle Behaviors Linked With Psoriasis DevelopmentLifestyle behaviors, such as body mass index and smoking, were shown to have a stronger association with psoriasis, regardless of genetic risk.
Latest:
How to Best Support Women With Menopausal AcneMenopausal acne is rising yet underexplored; treatment must address hormonal shifts, skin sensitivity, and patient emotional well-being.
Latest:
Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell CarcinomaIn part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.
Latest:
Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 3A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.
Latest:
Managing Atopic Dermatitis Postpartum and While BreastfeedingA patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.
Latest:
Late-Breaking Data: Phase 3 Updates on Ruxolitinib Cream for Prurigo NodularisShawn Kwatra, MD, FAAD, reviews his late-breaking data presentation at AAD on the first original studies of a topical cream for prurigo nodularis.
Latest:
Burnout, Frustration Levels Continue to Grow Among PhysiciansDoctors cite more support staff, reduced patient panels among solutions.
Latest:
Managing Your Pediatric Dermatology Practice and Life: Insights from Brandie Metz, MD, and Megha Tollefson, MDMetz and Tollefson share insights on efficient practice management, work-life balance, and exciting developments in pediatric dermatology.
Latest:
Q&A: How the PWRS Program and Inaugural Report is Empowering Women and Transforming Global HealthcareEve Arnera and Thandiwe Munaiwa, MD, spoke about the groundbreaking collaboration between SkinCeuticals and ReSurge International, “Pioneering Women in Reconstructive Surgery.”
Latest:
Q&A: Terri Phillips, MD, FAAP, Explores The Psychological Impact of Aesthetic ProceduresPhillips discusses Merz Aesthetics' recent research, which highlights how aesthetic treatments boost confidence, self-perception, and emotional well-being.
Latest:
How Can AI Improve Patient Care?AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.
Latest:
Drug Combination May Benefit Patients with Transplanted Kidneys, Advanced Skin CancersIn most kidney transplant recipients with advanced skin cancer, 2 checkpoint inhibitors are needed to boost the immune system, according to a new study.
